Feed CYAN
Summary
33 / 100 · Bulios Score
Valuation 59Growth 57Profitability 14Quality 14Debt 8Stability 52
What speaks for it
- The share price is below the Bulios Fair Price.
- Revenue grew by 4.8% a year over the last 3 years.
What to watch
- The company made a loss over the last 12 months.
- Repaying its net debt would take 8.2 years of operating profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price
Current price $0.63
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
20222023202420252026
Diluted EPS (USD)
20222023202420252026
Revenue fell by 5.9% a year over 5 years. Over the last 3 years it grew by 4.8% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $69.0K.
Profitability in detailIs it financially healthy?
Cash and short-term investments $1.09M
Debt $11.4M
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Packaged Products 39%
- Packaged Astaxanthin 28%
- Packaged Spirulina 11%
- Bulk Products 11%
- Bulk Astaxanthin 5.5%
- Other 5.1%
By region
- UNITED STATES 72%
- Asia Pacific 13%
- Europe 11%
- Other Countries 4.4%
Packaged Products brings in 39% of revenue.
Segments in detail